Search CommunityWalk:


Trophogen, Inc

6 Taft Court, Suite 150
Rockville, MD 20850, USA

Category: Biotechnology/Biopharmaceutical

Used in the following map:

Maryland Biotech Industry Map

Trophogen, Inc is a biotechnology company focused on the development of high affinity glycoprotein hormone and related growth factor analogs for human and animal infertility as well as targeted therapy and imaging of thyroid, ovarian, breast, prostate and testicular cancers. It was founded in 2001, with a mission to develop superactive hormones and growth factors for a wide array of therapeutic applications.

Trophogen technology represents the first successful design of super active analogs of glycoprotein hormones that shows major increases in bioactivity and far exceeds results shown for other protein ligands. Its platform technology of substituting amino acids in protein sequences based on electrostatic interactions has implications in a variety of therapeutic fields from infertility to cancer.

Trophogen product portfolio includes: FSH and LH superagonist for the treatment of human and animal infertility; Labeled TSH superagonist imaging agent for thyroid cancer; TSH superagonist- radionuclide or -toxin for the targeted therapy of thyroid cancer; LH and FSH superagonist- radionuclide or toxin for the targeted therapy of ovarian cancer; LH superagonist- radionuclide or toxin for the targeted therapy of breast and prostate cancer; etc.

Trophogen has established partnership with Bioniche Life Sciences Inc.